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Abstract
Background: The CMAP (Compound Muscle Action Potential) scan is a non-invasive electrodiagnostic tool, which
provides a quick and visual assessment of motor unit potentials as electrophysiological components that together
constitute the CMAP. The CMAP scan records the electrical activity of the muscle (CMAP) in response to
transcutaneous stimulation of the motor nerve with gradual changes in stimulus intensity. Large MUs, including
those that result from collateral reinnervation, appear in the CMAP scan as so-called steps, i.e., clearly visible jumps
in CMAP amplitude. The CMAP scan also provides information on nerve excitability. This study aims to evaluate the
influence of the stimulation protocol used on the CMAP scan and its quantification.
Methods: The stimulus frequency (1, 2 and 3 Hz), duration (0.05, 0.1 and 0.3 ms), or number (300, 500 and 1000
stimuli) in CMAP scans of 23 subjects was systematically varied while the other two parameters were kept
constant. Pain was measured by means of a visual analogue scale (VAS). Non-parametric paired tests were used to
assess significant differences in excitability and step variables and VAS scores between the different stimulus
parameter settings.
Results: We found no effect of stimulus frequency on CMAP scan variables or VAS scores. Stimulus duration
affected excitability variables significantly, with higher stimulus intensity values for shorter stimulus durations. Step
variables showed a clear trend towards increasing values with decreasing stimulus number.
Conclusions: A protocol delivering 500 stimuli at a frequency of 2 Hz with a 0.1 ms pulse duration optimized
CMAP scan quantification with a minimum of subject discomfort, artefact and duration of the recording. CMAP
scan variables were influenced by stimulus duration and number; hence, these need to be standardized in future
studies.
Keywords: CMAP scan, Stimulus–response curve, Settings, Stimulus number, Stimulus frequency, Stimulus
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Background
The CMAP (Compound Muscle Action Potential) scan
is a non-invasive neurophysiological tool, which
records the electrical activity of a muscle in response
to repetitive transcutaneous stimulation of the motor
nerve [1,2]. It is based on the fact that motor units
(MUs) differ with respect to the stimulus intensity that
is required to activate them, i.e., they have differing
thresholds. If the stimulus intensity is gradually
increased from subthreshold to supramaximal values,
all MUs in the muscle are successively activated. Plot-
ting the size of the resulting CMAP against the stimu-
lus intensity normally results in a smooth, sigmoid
curve: the CMAP scan (Figure 1A).
Large MUs, including those that result from collat-
eral reinnervation, will show in the CMAP scan as so-
called steps, i.e., clearly visible jumps in CMAP ampli-
tude (Figure 1B). Henderson et al. showed that patients
with amyotrophic lateral sclerosis (ALS) had more and
larger steps in the CMAP scan than healthy controls
[2]. Using a Bayesian algorithm, an estimation of the
number of functional MUs in a muscle (motor unit
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CMAP scan [3]. MUNE is particularly useful for the
monitoring of neurogenic disorders and traumatic
lesions, which are characterized by a loss of function-
ing MUs. The CMAP scan also provides basic informa-
tion on nerve excitability that cannot be obtained with
standard nerve conduction studies. With increasing SIs
the recorded CMAP will increase, depending on the
excitability of individual motor units. The excitability
parameters of the CMAP scan are the stimulus inten-
sities that elicit 5%, 50% and 95% of the maximum
CMAP (S5, S50 and S95 respectively, see Figure 1A)
and the range between the S5 and S95.
This information can contribute to the diagnosis and
monitoring of demyelinating diseases such as Guillain-
Barré syndrome (GBS) [1]. Because all MUs contribute,
the CMAP scan is not affected by sample bias that would
favor certain subpopulations of MUs over others.
A lot of research on the effect of stimulus duration on
nerve excitability has been done and it is well known
that using a shorter stimulus duration results in a higher
stimulus intensity needed to elicit the same CMAP amp-
litude [4-6]. Little is known about the influence of stimu-
lus parameters such as stimulus frequency and the total
number of stimuli on the properties of trains of recorded
CMAPs, and, hence, on the CMAP scan. Especially the
effect on the amount and size of steps in the CMAP scan
is not known. To develop the CMAP scan as a clinical
tool, the effect of the stimulus settings on the CMAP
scan and its quantification must be defined to enable
standardized collection of normal values and comparison
of CMAP scan data between medical centers. The aim of
the present study was to determine the optimal stimulus
parameters settings for frequency, pulse duration and
number, balancing between minimal subject discomfort,
artefacts, and recording duration, while optimizing stan-
dardized quantification of the CMAP scan.
Methods
Subjects and design
The study was performed in Rotterdam, the Netherlands,
and Brisbane, Australia. In total, 23 subjects were included
(age, 25–67 years). In 17 of these (11 in Rotterdam, 6 in
Brisbane), the median nerve was studied and in the other
6 (all Brisbane), ulnar nerve recordings were made. The ef-
fect of stimulus frequency (1, 2, and 3 Hz) and stimulus
duration (0.05, 0.1, and 0.3 ms) was studied in Rotterdam.
The effect of the number of stimuli (300, 500, and 1000)
was studied in Brisbane. For each parameter, the three
values were chosen such that they represented both realis-
tic extremes and the expected optimum. For example,
based on our previous work, we already knew that using
fewer that 300 stimuli often results in spurious steps, while
using more than 1000 makes the duration of the registra-
tion impractically long for diagnostic purposes.
Carpal tunnel syndrome (for median nerve testing) and
ulnar neuropathy (for ulnar nerve testing) were excluded
by means of conventional nerve conduction studies. None
of the subjects had symptoms or signs of neurological dis-
ease. The experimental protocol was approved by the insti-
tutional Medical Ethics Committees in Rotterdam and
Brisbane. All subjects gave informed consent.
Recordings
The CMAP scan was recorded using a dedicated pro-
gram on a Nicolet VikingSelect EMG system (Care-
Fusion, San Diego, CA). This program allows parameters
such as stimulus frequency, duration, number, and
Figure 1 A: CMAP scan with 500 stimulus–response combinations collected in a normal subject. CMAP amplitude increases with increasing
stimulus intensity. The maximum CMAP amplitude is indicated with the horizontal dotted line. S5, S50, and S95 are the stimulus intensities that
elicited responses with a size of 5, 50, and 95 percent of the maximum CMAP, respectively (dotted vertical lines). B: CMAP scan in a 76 year old
patient with amyotrophic lateral sclerosis, six months after diagnosis. The CMAP scan clearly differs from the CMAP scan of the healthy subject
due to the many steps in the curve. The maximum CMAP amplitude is 3.2, as indicated with the horizontal dotted line. The two largest steps are
indicated with arrows. The largest step in this CMAP scan is 0.9 mV which comprises 28% of the maximum CMAP. The step percentage is the
summation of all steps in the CMAP scan. In this case the sum of all steps is almost 2.2 mV which is 68% of the maximum CMAP. The step
percentage of this CMAP scan is therefore 68%.
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ged easily. It displays and stores the absolute area and
amplitude of the negative peak of the elicited CMAPs and
the relative area and amplitude (as percentage of the area
or amplitude of the recorded maximal CMAP), of each of
the responses.
CMAP scan recordings were obtained from the thenar
muscles for the median nerve and the hypothenar mus-
cles for the ulnar nerve using 10 mm diameter, silver-sil-
ver chloride cup electrodes. The active electrode was
placed over the muscle belly, and optimized for max-
imum CMAP size, negative onset, and biphasic shape.
The reference electrode was placed on the metacarpal-
phalangeal joint of the thumb for the median nerve and
on the proximal interphalangeal joint of the fifth digit
for the ulnar nerve. The ground electrode (self-adhesive
surface electrode) was placed on the dorsum of the hand.
In Rotterdam, the stimulator consisted of two 6 x
20 mm rectangular felt electrodes with an interelectrode
distance of 20 mm, attached with a strap to the wrist
with a minimum of surface compression. In Brisbane,
the stimulating electrodes were 10 mm, silver-silver
chloride cup electrodes taped to the skin. In both cen-
ters, the stimulator was applied to the wrist at the point
of lowest threshold, an important factor to ensure reli-
able and reproducible quantification of stimulus intensity
variables since stimulus intensity variables depend
strongly on the relative location of the stimulus electro-
des to the axons in the nerve trunk. The hand was
immobilized and the thumb or fifth finger was taped to
the side of the hand to avoid movement artefacts. Sub-
jects were asked to remain relaxed, silent, and motionless
during the recordings.
Recordings started with the determination of the low-
est stimulus intensity (S0), measured in mA, that elicited
an all-or-none response of the lowest-threshold MU.
Next, the maximum CMAP was determined by increas-
ing the stimulus intensity until the recorded CMAP was
maximal and then turned up by another 30% to ascertain
that all MUs had been activated (supramaximal stimula-
tion). Third, the lowest stimulus intensity (S100 or max-
imal stimulation) at which the maximum CMAP could
be recorded was determined and rounded to the next-
highest integer value in mA. The final preparatory step
consisted of a test scan of 30 stimuli to confirm that S0
and S100 were set correctly. If necessary, S0 and S100
were adjusted to ensure that the scan covered the entire
CMAP range.
The experimental testing comprised a series of three
CMAP scans in which one of the stimulus parameters
was systematically varied. Each session started with
standard settings (2 Hz, 1 ms, 500 stimuli), followed by
the remaining two variants of the parameter under study.
When one parameter was varied, all others were kept at
the standard settings. The low and high settings of each
parameter were studied alternately in subsequent sub-
jects to avoid systematic bias due to fatigue or other
order-dependent effects.
There was a pause of at least 3 minutes between record-
ings. After each CMAP scan, the eleven subjects studied
in Rotterdam indicated the severity of experienced pain
on a visual analogue scale (VAS) [7], which ranged from 0
(no pain) to 10 (most severe pain conceivable).
The CMAP scans performed with the standard settings
were used for the evaluation of intercenter variability.
Data analysis
All CMAP scans were analysed in Rotterdam. A quality
check on the data was performed in Excel 2003 (Micro-
soft, Redmond, WA, USA) to identify obvious movement
artefacts that were then removed by deleting the affected
samples from the CMAP scan. For quantitative analysis,
the data were subsequently imported in MATLAB (ver-
sion R2008a, The MathWorks, Natick, MA, USA), using
a program written specifically for this purpose. From
each scan, the maximum CMAP (amplitude and area of
the negative peak), excitability and step variables were
determined. To quantify excitability, we first determined
the stimulus intensities that elicited the responses closest
to 5%, 50%, and 95% of the maximum CMAP amplitude
(S5, S50, and S95, respectively; see Figure 1A). From
these values, we derived the absolute stimulus intensity
range as the difference between S95 and S5, and the rela-
tive stimulus intensity range (absolute range divided by
S5). We used S5 and S95 rather than S0 and S100 to
minimize influence of noise (at the low end of the scan)
and decrement effects (at the high end, see Discussion)
on the excitability variables. Steps were quantified by the
maximum step size (absolute size of the largest step in
the scan, in μV, and relative size as percentage of the
maximum CMAP amplitude), total step size (cumulative
absolute size of the steps), step percentage (cumulative
step size as a percentage of the maximum CMAP ampli-
tude) and step number.
The maximum CMAP, S5, S50, S95 and the derived ex-
citability variables were determined automatically by the
program. The analysis of the steps was semi-automatic, in
the sense that steps were identified by selecting them in
the CMAP scans with a mouse click, after which the pro-
gram automatically determined the values for the various
step variables indicated above. For the purpose of identifi-
cation and selection, steps were defined as clear gaps in
the CMAP scan that were bounded by two plateaus (at the
upper and lower end of the gap), each of which consisted
of at least 3 consecutive responses of about the same size
(i.e., disregarding noise). Steps smaller than 2% of the max-
imum CMAP and localized in the lower (<5%) or upper
(>95%) end of the CMAP scan are probably caused by the
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thresholds. These steps occur frequently in normal sub-
jects as well as patients, and were, therefore, not included
in the step variables as described above.
Statistical analysis
SPSS (SPSS Inc, Chicago, IL, USA; version 15.0.1) was
used for statistical analysis of the data. Because the data
were not normally distributed, non-parametric paired
tests (Friedman test and Wilcoxon signed ranks test)
were used to assess significant differences in the CMAP
scan variables and VAS scores between the different
stimulus parameter settings (stimulus frequency, dur-
ation, and number). Since we performed multiple tests
we used a significance level of p<0.01.
Results
In total, 98 CMAP scans were recorded. The effect of
stimulus duration was not studied in 1 subject because of
lack of time. All CMAP scans were of good quality for ana-
lysis. The median VAS score for CMAPs scans recorded
with the common protocol (2 Hz, 0.1 ms and 500 stimuli)
was 1.0 (range, 0–1.8) on a scale from 0 to 10. CMAP
scans and derived variables were similar for the median
and ulnar nerves, although there was a trend toward higher
ulnar nerve excitability values (Table 1). There were no sig-
nificant differences in the CMAP scan variables between
Brisbane and Rotterdam, although step percentage
(p=0.03) tended to be lower in Brisbane (Table 1).
We found no effect of stimulus frequency on the
CMAP scan variables (p>0.1) and VAS scores (p=0.34)
(Table 2). Stimulus duration affected S5, S50, S95, and
the absolute and relative range significantly (p<0.005),
with higher stimulus intensity values for shorter stimulus
durations (Table 3), but there was no relation with the
step variables, maximum CMAP, and VAS score.
Table 4 shows the results for the step variables as a
function of the number of stimuli. The 500-stimuli and
1000-stimuli CMAP scans proved to be similar.
Differences in step percentage existed primarily between
these and the 300-stimuli scans (p=0.005 for 300 vs 500
stimuli and p=0.004 for 300 vs 1000 stimuli). Differ-
ences in step number were not significant at the p=0.01
level, but showed a clear trend towards increasing step
number with decreasing stimulus number. The excitabil-
ity variables did not change with stimulus number.
Discussion
This study examined the stimulus parameters involved in
the CMAP scan, aiming to optimize its quantification
and minimize subject discomfort. Our results show that
both stimulus duration and number of stimuli need to
be standardized in CMAP scan studies, to ensure that
data of different studies can be compared and normative
data established. As is already known, stimulus duration
has an effect on the excitability variables (Table 3) [4-6].
For the CMAP scan, determination of an optimal value
for this parameter is somewhat arbitrary, however. A
shorter stimulus duration decreases the steepness of the
CMAP scan (the slope of the steep portion of the scan,
expressed in mV/mA) and MU thresholds become more
separated. Furthermore, the resolution of our stimulator
is limited to 0.01 mA; smaller increases in stimulus in-
tensity cannot be set. This implies that, if the absolute
range of a CMAP scan is less than 5 mA, some inten-
sities will be used more than once for stimulation with
500 stimuli. Even at stimulus duration of 0.1 ms, this is
quite common. In other words, using shorter stimulus
durations will allow sampling at a greater number of dif-
ferent stimulus intensities and thereby increase the reso-
lution of the CMAP scan. The disadvantage of using
short stimulus durations such as 0.05 ms is that the ma-
chine-imposed safety limit of 100 mA is reached more
easily. This implies that in patients with increased
thresholds such as in Guillain-Barré syndrome, the high
end of the CMAP scan may be missed. Based on these
practical issues, we therefore recommend for the CMAP
scan stimulating with a pulse duration of 0.1 ms.
Table 1 Results (median and range) with standard protocol
Variable Rotterdam Brisbane median Brisbane ulnar
(n=11) (n=6) (n=6)
Max CMAP (mV) 9.5 (6.9–13.5) 11.8 (6.5–12.6) 11.0 (9.7–14.4)
S5 (mA) 8.5 (6.4–16.0) 9.0 (7.8–13.9) 11.3 (8.7–22.1)
S50 (mA) 10.6 (8.2–20.9) 11.5 (9.6–16.0) 13.8 (11.6–27.1)
S95 (mA) 13.3 (9.6–24.5) 14.3 (11.2–20.3) 17.4 (15.6–33.6)
Range (mA) 5.0 (2.7–8.9) 5.3 (2.8–8.2) 7.6 (5.4–11.5)
Relative Range 0.44 (0.35–0.88) 0.53 (0.34–0.79) 0.63 (0.45–0.99)
Step Number 2( 0 –7) 0.5 (0–5) 0.5 (0–4)
Step percentage (% ) 4.9 (0.0–15.9) 0.3 (0–10.9) 0.3 (0–9.2)
Differences between centers and nerves were statistically not significant (p>0.01).
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variables in healthy subjects (Table 2). However, in gen-
eral, a high frequency increases the chance of decre-
ments [8-10]. Decrements are systematic decreases in
the CMAP in response to series of stimuli of equal
strength. These may be due to disorders of neuromuscu-
lar transmission, but small decrements (<10% of the
maximum CMAP area) can also occur in healthy sub-
jects and patients with ALS. Such decrements in CMAP
area extend over the first 5 to 50 stimuli, and are pos-
sibly due to an increased muscle fiber conduction vel-
ocity or changes in the nerve or muscle membrane
[9,10]. Given the repetitive nature of the stimulation
used for the CMAP scan, small decrements might there-
fore be expected and indeed were observed in our study,
particularly during the first 5 stimuli. This decrement ef-
fect, which complicates CMAP scan quantification and
interpretation, appears to be smaller for 2 Hz than for
3 Hz [9,10]. This would favour low-frequency stimula-
tion. However, compared to 2 Hz, stimulating with 1 Hz
doubles the recording time and, hence, increases the risk
of movement artefacts. Stimulating with 2 Hz appears
the best compromise to minimize decrements and move-
ment artefacts at reasonable recording time. In this con-
text, it should also be noted that the size of the
decrement decreased with fixation of the thumb to the
side of the hand. This constriction of movement reduces
muscle fiber shortening, and hence limits the change in
muscle fiber conduction velocity [11,12]. Fixation is,
therefore, highly recommended.
The presence of multiple steps is a hallmark of abnor-
mal CMAP scans [1,2,13]. It is, therefore, particularly
important to standardize CMAP scan stimulation set-
tings that may influence the step parameters. Differences
in step percentage between scans with 300 and 500 stim-
uli and between scans with 300 and 1000 stimuli were
significant. Differences in step number were not signifi-
cant, but showed a clear trend (Table 4). The increase in
step percentage and step number with decreasing stimu-
lus number most likely results from undersampling of
the steep part of the scan and, hence, the introduction of
spurious steps. Differences in step percentage and step
Table 2 Results (median and range) for different stimulus frequencies
Variable 1 Hz 2 Hz 3 Hz
(n=11) (n=11) (n=11)
Max CMAP (mV) 9.4 (6.9–13.2) 9.5 (6.9–13.5) 9.5 (6.9–12.5)
S5 (mA) 8.9 (5.9–22.0) 8.5 (6.4–16.0) 9.0 (6.0–18.6)
S50 (mA) 11.2 (8.5–29.0) 10.6 (8.2–20.9) 11.1 (8.3–26.6)
S95 (mA) 13.6 (9.7–34.3) 13.3 (9.61–24.5) 13.5 (9.5–31.1)
Range (mA) 5.0 (2.4–12.3) 5.0 (2.7–8.9) 4.5 (2.3–12.6)
Relative Range 0.50 (0.32–0.99) 0.44 (0.35–0.88) 0.49 (0.33–0.97)
Step Number 2( 0 –5) 2 (0–7) 1 (0–6)
Step percentage (% ) 4.7 (0–15.8) 4.9 (0–15.9) 4.0 (0–11.7)
VAS 1.0 (0.1–5.1) 1.0 (0.0–1.8) 1.2 (0.1–3.8)
Standard protocol was 500 stimuli, 2hz, 0.1 ms
Results for the different stimulus frequencies (1 Hz, 2 Hz, and 3 Hz). None of the differences between the parameters were significant.
Table 3 Results (median and range) for different stimulus durations
Variable 0.05 ms 0.1 0.3 ms
(n=10) (n=11) (n=10)
Max CMAP (mV) 10.9 (4.7–12.9) 9.5 (6.9–13.5) 10.9 (4.7–12.9)
S5 (mA) 13.4* (9.4–29.5) 8.5* (6.4–16.0) 4.4* (2.8–10.0)
S50 (mA) 16.1* (11.5–34.7) 10.6* (8.2–20.9) 5.2* (3.5–12.4)
S95 (mA) 18.8* (14.2–39.6) 13.3* (9.61–24.5) 6.3* (4.6–14.9)
Range (mA) 5.6* (3.8–10.1) 5.0* (2.7–8.9) 2.0* (1.6–4.8)
Relative Range 0.46* (0.27–0.61) 0.44* (0.35–0.88) 0.51* (0.34–0.70)
Step Number 2 (0.8) 2 (0–7) 1.5 (0–5)
Step percentage (% ) 1.9 (0–5.5) 4.9 (0–15.9) 2.9 (0–10)
VAS 1.2 (0.0–3.2) 1.0 (0.0–1.8) 1.0 (2.7–2.4)
The excitability parameters all differed significantly (p<0.01) between all stimulus durations settings (indicated with *). For example, S5 with 0.05 ms differs
significantly from 0.1 ms and from 0.3 ms.
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were small and not significant (Table 4). This suggests
that 500 stimuli provide sufficient detail in the steepest
part of the scan. Moreover, recording a CMAP scan with
1000 stimuli extends the duration of the test, which
increases the risks of movement artefacts and patient
discomfort. Hence, we prefer 500 stimuli for the record-
ing of the CMAP scan. This does require, however, that
the stimulus limits (S0 and S100) are set correctly so
that most of the responses are in the steep portion of
the scan and not in the tails. It should also be noted that
specific applications, such as the Baysian MUNE ana-
lysis [3], may yet require 1000 or more stimuli.
During our previous work on the CMAP scan, we
noted that a downwards recording direction appeared to
ne better tolerated. Although downward recordings gen-
erally require exclusion of a number of decremental
responses at the top of the CMAP scan from the ana-
lysis, at least this is feasible. In upward scanning, the ef-
fect of decrements cannot be separated from the
variability in the scan that is due to alternation and MU
recruitment. For that reason, and because it seems to be
better tolerated, we consider downward recording
preferable.
Inter-center variability
There were no significant differences in the mean values
of the CMAP scan variables between the two centers and
their ranges were similar. Nevertheless, step variables
showed a trend towards lower values in Brisbane. All
data were analysed by the same researcher, so no inter-
observer variability can have occurred in the step detec-
tion. Differences could be the result of the small number
of subjects in whom the median nerve was assessed in
Brisbane (n=6). Another factor that may explain the
lower step values in Brisbane is that those CMAP scans
had fewer responses at subthreshold stimulus intensities
(the lower tail). This resulted in more stimuli in the
middle part of the CMAP scan and, hence, fewer spuri-
ous steps and smaller step size.
Conclusions
The optimal recording parameters for the CMAP scan
are: stimulus duration of 0.1 ms, stimulus frequency of
2 Hz, and a stimulus number of 500 with a downwards
recording direction. These stimulation settings optimize
CMAP scan quantification and minimize subject dis-
comfort, artefacts and recording time. Stimulus number
and duration need to be standardized in future CMAP
scan studies.
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